• 2007

Company Description

Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.

Vaccinogen, Inc. operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery. The company was incorporated in 2007 and is based in Frederick, Maryland.